US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | argenx SE | $877.72 | -1.6% | $54.32B | 44.7 | 279.7% | — | Healthcare | 63.2% | 174% | ||
| 2 | Spyre Therapeutics, Inc. | $88.34 | 1% | $30.57B | -44.6 | 12.4% | — | Healthcare | 485.8% | — | ||
| 3 | TG Therapeutics, Inc. | $53.22 | 3.3% | $8.15B | 19.2 | 1070.7% | — | Healthcare | 51.3% | 81.3% | ||
| 4 | Kymera Therapeutics, Inc. | $90.43 | 0.6% | $7.38B | -24.5 | -15.5% | — | Healthcare | 94.7% | -12.6% | ||
| 5 | Protagonist Therapeutics, Inc. | $112.86 | 1.3% | $7.26B | -55.1 | -341.3% | — | Healthcare | 109.3% | -91.5% | ||
| 6 | Immunovant, Inc. | $35.34 | 1.8% | $7.26B | -12.8 | -1.5% | — | Healthcare | 122.8% | — | ||
| 7 | Abivax S.A. | $99.15 | -1% | $6.5B | -18.6 | 16.6% | — | Healthcare | 1538.8% | -100% | ||
| 8 | Apogee Therapeutics, Inc. | $90.38 | 2.2% | $5.59B | -21.4 | -19.3% | — | Healthcare | 119.5% | — | ||
| 9 | Apellis Pharmaceuticals, Inc. | $41.03 | 0% | $5.25B | 227.9 | 150.8% | — | Healthcare | 131% | 32.6% | ||
| 10 | Kiniksa Pharmaceuticals, Ltd. | $55.11 | 1.7% | $4.09B | 73.5 | 471.4% | — | Healthcare | 97.3% | 56.7% | ||
| 11 | Dianthus Therapeutics, Inc. | $82.49 | 0.7% | $3.44B | -19.6 | 96.2% | — | Healthcare | 373% | -79.5% | ||
| 12 | Forte Biosciences, Inc. | $17.85 | 1.5% | $3.18B | -3.8 | 66.8% | — | Healthcare | 43.4% | — | ||
| 13 | Alumis Inc. Common Stock | $23.41 | 1.6% | $2.93B | -8.2 | 69.7% | — | Healthcare | 677.7% | -51.7% | ||
| 14 | Oruka Therapeutics, Inc. | $72.34 | 2.1% | $2.71B | -31.3 | 54.5% | — | Healthcare | 503.8% | — | ||
| 15 | Vera Therapeutics, Inc. | $35.09 | 0.2% | $2.52B | -7.5 | -77% | — | Healthcare | 67.7% | — | ||
| 16 | AnaptysBio, Inc. | $57.51 | 1.3% | $2.48B | -125.0 | 78% | — | Healthcare | 268.9% | 107.7% | ||
| 17 | Aurinia Pharmaceuticals Inc. | $16.46 | 2% | $2.12B | 8.0 | 675.6% | — | Healthcare | 107.8% | 20.6% | ||
| 18 | Galapagos N.V. | $27.98 | 2.2% | $1.84B | 5.0 | 379.9% | — | Healthcare | -0.9% | 262.2% | ||
| 19 | ZyVersa Therapeutics, Inc. | $0.19 | 11.6% | $1.53B | -0.0 | 57.3% | — | Healthcare | -72.6% | -100% | ||
| 20 | KalVista Pharmaceuticals, Inc. | $27.00 | 0% | $1.44B | -8.4 | 13.9% | — | Healthcare | 119.3% | — | ||
| 21 | MoonLake Immunotherapeutics | $19.21 | 0.1% | $1.41B | -5.4 | -68.7% | — | Healthcare | -55.8% | — | ||
| 22 | Nektar Therapeutics | $60.98 | 0.1% | $1.19B | -6.3 | 11.6% | — | Healthcare | 608.2% | -36.2% | ||
| 23 | Ventyx Biosciences, Inc. | $14.00 | 0% | $999M | -7.1 | 36.4% | — | Healthcare | 490.7% | — | ||
| 24 | Annexon, Inc. | $4.90 | -0.8% | $952M | -3.7 | -3.4% | 0.2% | Healthcare | 109.4% | — | ||
| 25 | DBV Technologies S.A. | $15.53 | -4.6% | $919M | -0.6 | 11.8% | — | Healthcare | 57.7% | -100% | ||
| 26 | Zenas BioPharma, Inc. | $19.78 | 6.5% | $883M | -2.3 | -129.2% | — | Healthcare | 112.5% | -100% | ||
| 27 | Climb Bio, Inc. | $11.45 | 1% | $781M | -13.0 | 67.2% | — | Healthcare | 830.9% | — | ||
| 28 | Omeros Corporation | $10.28 | 6.6% | $744M | -195.1 | 149.1% | — | Healthcare | 219.3% | — | ||
| 29 | Rigel Pharmaceuticals, Inc. | $32.91 | -1.4% | $609M | 1.7 | 804.3% | — | Healthcare | 70% | 47.6% | ||
| 30 | Gyre Therapeutics, Inc. | $6.25 | 2.8% | $606M | 277.8 | -8.9% | — | Healthcare | -25% | 16.3% | ||
| 31 | FibroGen, Inc. | $7.50 | 0.3% | $585M | -15.6 | 678.3% | 0.3% | Healthcare | 45.3% | -218.3% | ||
| 32 | Jade Biosciences, Inc. | $16.82 | -0.3% | $549M | -4.1 | 95.6% | — | Healthcare | 78.7% | — | ||
| 33 | Palisade Bio, Inc. | $1.87 | 6.3% | $392M | -6.2 | 83.6% | — | Healthcare | 192% | — | ||
| 34 | RAPT Therapeutics, Inc. | $58.01 | 0% | $296M | -2.3 | 50.2% | — | Healthcare | 681.7% | — | ||
| 35 | Equillium, Inc. | $3.05 | 2% | $294M | -7.8 | 2.9% | — | Healthcare | 845.7% | -100% | ||
| 36 | Cartesian Therapeutics, Inc. | $9.63 | -2.5% | $283M | -1.9 | -325.7% | — | Healthcare | -3.7% | -94.8% | ||
| 37 | Zura Bio Limited | $3.75 | 3.6% | $244M | -3.5 | -29.8% | — | Healthcare | 237.8% | — | ||
| 38 | Eledon Pharmaceuticals, Inc. | $3.92 | 5.9% | $235M | -7.0 | 60.7% | — | Healthcare | 41% | — | ||
| 39 | Avalo Therapeutics, Inc. | $14.70 | -4.5% | $166M | -2.5 | -124.1% | — | Healthcare | 208.8% | -86.6% | ||
| 40 | Q32 Bio Inc. | $11.90 | -7.8% | $152M | 4.9 | 153.8% | — | Healthcare | 643.8% | — | ||
Showing 40 of 71 stocks